Endothelin Receptor Function and Acute Stress (End-Stress)
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2019
Price : $35 *
At a glance
- Drugs Bosentan (Primary)
- Indications Acute traumatic stress disorders
- Focus Therapeutic Use
- Acronyms End-Stress
- 07 Oct 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Apr 2020.
- 17 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2014 Planned initiation date changed from 1 May 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.